image
Healthcare - Biotechnology - NASDAQ - US
$ 6.69
-11.6 %
$ 427 M
Market Cap
-5.82
P/E
BALANCE SHEET
95.9 M ASSETS
-24.11%
14.2 M LIABILITIES
-8.30%
81.7 M EQUITY
-26.31%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Larimar Therapeutics, Inc.
image
Current Assets 90.2 M
Cash & Short-Term Investments 86.8 M
Receivables 0
Other Current Assets 3.38 M
Non-Current Assets 5.76 M
Long-Term Investments 1.34 M
PP&E 3.76 M
Other Non-Current Assets 659 K
Current Liabilities 9.51 M
Accounts Payable 1.28 M
Short-Term Debt 837 K
Other Current Liabilities 7.39 M
Non-Current Liabilities 4.71 M
Long-Term Debt 4.71 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
ASSETS
Cash & Cash Equivalents 26.7 26.8 70.1 68.1 1.0 49.3 40.8 32.4 35.6 58.1
Short Term Investments 60.0 91.6 0 24.5 43.0 68.7 61.3 96.8 149.5 57.4
Receivables 0 0 0.2 32 K 0 1.5 0.9 0.3 1.3 0
Inventory 0 0 (0.2) 32 K 3.2 0 0 1 0 0
Other Current Assets 3.4 2.3 1.9 5.3 3.7 2.2 1.9 1.4 1.7 1.7
Total Current Assets 90.2 120.7 72.2 98.0 4.8 121.3 104.9 130.9 188.1 117.2
PP&E 3.8 3.7 4.5 5.0 0.4 0.4 0.5 0.7 0.9 79 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0
Long Term Investments 1.3 1.3 1.3 1.3 0 0 0 0 0 0
Other Long Term Assets 0.7 0.6 0.7 0.4 90 K 57 K 57 K 61 K 94 K 0.2
Other Assets 0 0 0 0 0 0 0 0 1 0
Total Assets 95.9 126.4 78.7 104.7 5.2 121.8 105.5 131.6 189.1 117.5
LIABILITIES
Accounts Payable 1.3 1.7 1.7 2.6 3.5 0.9 3.0 2.6 7.5 2.3
Short Term Debt 0.8 1.2 1.2 1.0 97 K 5.5 0 3.6 2.9 1.4
Other Current Liabilities 7.4 7.8 6.0 5.3 2.3 6.9 4.3 6.3 9.0 3.2
Total Current Liabilities 9.5 10.7 8.8 9.0 5.9 13.3 7.3 9.9 16.5 6.9
Long Term Debt 4.7 4.8 5.4 6.0 0 15.2 20.0 0 3.5 6.2
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 1 0
Total Liabilities 14.2 15.5 14.3 15.0 5.9 28.5 27.3 9.9 20.0 13.1
EQUITY
Common Stock 43 K 43 K 18 K 15 K 6 K 37 K 27 K 27 K 27 K 23 K
Retained Earnings (188.6) (151.6) (116.2) (65.6) (23.1) (350.9) (289.6) (237.5) (179.7) (105.4)
Other Accumulative Comprehensive Income/Loss 81 K 31 K 0 1 K 35 K 33 K 58 K 80 K (0.2) 35 K
Total Equity 81.7 110.9 64.4 89.7 (0.7) 93.3 78.2 121.7 169.1 104.4
Total Liabilities and Equity 95.9 126.4 78.7 104.7 5.2 121.8 105.5 131.6 189.1 117.5
SHARES OUTSTANDING
Common Shares Outstanding 43.9 25.8 17.2 11.9 9.2 2.7 2.3 2.3 2.2 2.4